fluorodeoxyglucose f18 has been researched along with Amino Acid Metabolism Disorders, Inborn in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byrne, BJ; Chen, PW; Cheng, CH; Chien, YH; Hu, MK; Hwu, WL; Lee, NC; Liu, WS; Muramatsu, S; Tzen, KY; Wang, WH | 1 |
| Richardson, RM; Zwagerman, NT | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Amino Acid Metabolism Disorders, Inborn
| Article | Year |
|---|---|
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal; Blood Pressure; Brain; Dependovirus; Disease Models, Animal; Dopamine; Enzyme Activation; Fluorodeoxyglucose F18; Gene Expression; Genetic Therapy; Genetic Vectors; Heart Rate; Immunohistochemistry; Mice; Mice, Transgenic; Motor Activity; Neurons; Neurotransmitter Agents; Organ Specificity; Positron-Emission Tomography; Transduction, Genetic; Weight Gain | 2015 |
Gene therapy for aromatic L-amino acid decarboxylase deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Clinical Trials as Topic; Fluorodeoxyglucose F18; Genetic Therapy; Humans; Positron-Emission Tomography | 2012 |